Peripheral Neuropathy Trial, Recruiting NCT03612193 Sponsor: Washington University School of Medicine Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT03612193
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Complex Regional Pain Syndrome (CRPS) — Study A:

  • Adults aged 18 or older
  • People who have been diagnosed with Complex Regional Pain Syndrome (a chronic pain condition) within the last year, or who were diagnosed more than a year ago, where the diagnosis was made using a specific set of medical standards called the Budapest criteria
  • People whose primary language is English
  • People who are able to give their own consent to participate

For household members — Study A:

  • Adults aged 18 or older
  • People who live in the same home as someone who has, or has had, a diagnosis of CRPS

For people with Complex Regional Pain Syndrome (CRPS) — Study B:

  • Adults aged 18 or older
  • People who have been diagnosed with CRPS within the last 6 months, where the diagnosis was made using the Budapest criteria
  • People whose primary language is English
  • People who are able to give their own consent to participate

For household members — Study B:

  • Adults aged 18 or older
  • People who live in the same home as someone who has been diagnosed with CRPS

Who may not be able to join:

  • People who are not willing to take part in the study
  • People who live alone
  • People currently taking probiotic supplements who are not willing to stop taking them for at least one week before providing a stool sample
  • People who are currently pregnant or breastfeeding
  • People who follow a vegan diet

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lara Crock, MD PhD, Washington University School of Medicine

Phone: 314-546-3882

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 December 2018
Est. completion
1 July 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of participants with taxonomic and metabolomic differences of the gut microbiome in relation to CRPS severity score; Number of participants with taxonomic and metabolomic differences of the gut microbiome in relation to recovery from CRPS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov